ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,417.60
0.28%
S&P ASX All Technology
3,879.80
1.02%
Brent Oil
73.23
-2.06%
US Dollar vs AUD
1.5361
-0.15%
Bitcoin
95,183.17
-2.92%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Canada
  5. TSX

  6. BELLUS Health Inc (BLU) Share Price

BELLUS Health Inc

BELLUS Health Inc (BLU)

Blue Energy Limited
Blue Star Capital Plc
19.48
0.00
( 0.00% )
Updated: 11:00:00
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
19.48
Bid
19.46
Offer
19.52
Volume
-
0.00 Day's Range 0.00
19.48 52 Week Range 19.48
Previous Close
19.48
Open
-
Last Trade
Last Trade Time
-
Average Volume (3m)
-
Financial Volume
-
VWAP
-

Ask ADVFN Intelligence (AI)

BLU Latest News

More News

Annonce boursière - Réservée aux médias et aux investisseurs - GSK mène à terme l'acquisition de BELLUS Santé

Annonce boursière - Réservée aux médias et aux investisseurs - GSK mène à terme l'acquisition de BELLUS Santé Canada NewsWire LONDON, le 28 juin 2023...

29 June 2023
PR Newswire (Canada)

Stock-exchange announcement - For media and investors only - GSK completes acquisition of BELLUS Health

Stock-exchange announcement - For media and investors only - GSK completes acquisition of BELLUS Health Canada NewsWire LONDON, June 28, 2023 LONDON, June 28, 2023 /CNW/ - GSK plc (LSE: GSK...

29 June 2023
PR Newswire (Canada)

S&P Dow Jones Indices annonce des modifications à l'indice composé S&P/TSX et à l'indice S&P/TSX 60

S&P Dow Jones Indices annonce des modifications à l'indice composé S&P/TSX et à l'indice S&P/TSX 60 Canada NewsWire TORONTO, le 2 sept. 2022 TORONTO, le 2 sept...

03 September 2022
PR Newswire (Canada)

S&P Dow Jones Indices Announces Changes to the S&P/TSX Composite Index and S&P/TSX 60 Index

S&P Dow Jones Indices Announces Changes to the S&P/TSX Composite Index and S&P/TSX 60 Index Canada NewsWire TORONTO, Sept. 2, 2022 TORONTO, Sept. 2, 2022 /CNW/ - As a result of the...

03 September 2022
PR Newswire (Canada)

BELLUS Santé présentera les plus récentes données cliniques de l’essai SOOTHE de phase 2b du BLU‑5937 à la ATS 2022 International Conference

BELLUS Santé inc. (Nasdaq : BLU; TSX : BLU) (« BELLUS Santé » ou la « société »), une société biopharmaceutique au stade clinique qui développe de nouveaux produits thérapeutiques pour le...

02 May 2022
Business Wire

BELLUS Health to Participate in Multiple Upcoming Investor Conferences

BELLUS Health Inc. (Nasdaq:BLU; TSX:BLU) (“BELLUS Health” or the “Company”), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of refractory chronic cough...

26 April 2022
Business Wire

BELLUS Health to Participate in the Cowen & Co. 42nd Annual Health Care Conference

BELLUS Health Inc. (Nasdaq:BLU; TSX:BLU) (“BELLUS Health” or the “Company”), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of refractory chronic cough...

01 March 2022
Business Wire
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10019.4819.4819.4800CS
40019.4819.4819.4800CS
120019.4819.4819.4800CS
260019.4819.4819.4800CS
520019.4819.4819.4800CS
15612.12164.6739130437.3619.96.36237612.08484387CS
26010.08107.2340425539.419.92.7982658.6197709CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
VRTSVertiqal Studios Corporation
$ 0.015
(50.00%)
10k
FLNTFlint Corporation
$ 0.035
(40.00%)
17.45k
CIXCI Financial Corp
$ 31.25
(30.15%)
1.02M
XLYAuxly Cannabis Group Inc
$ 0.04
(14.29%)
21.99k
NUMINuminus Wellness Inc
$ 0.05
(11.11%)
43.47k
BCHTBirchtech Corp
$ 0.75
(-16.67%)
8.7k
AVLAvalon Advanced Materials Inc
$ 0.035
(-12.50%)
177.19k
CWEBCharlottes Web Holdings Inc
$ 0.17
(-10.53%)
10.83k
HUTHut 8 Corp
$ 33.10
(-8.66%)
282.9k
FSYForsys Metals Corp
$ 0.65
(-8.45%)
4.99k
BAMBrookfield Asset Management Ltd
$ 78.50
(1.29%)
5.25M
BNGBengal Energy Ltd
$ 0.015
(200.00%)
1.76M
CIXCI Financial Corp
$ 31.25
(30.15%)
1.34M
ABXBarrick Gold Corporation
$ 24.46
(-4.04%)
748.31k
BITFBitfarms Ltd
$ 2.85
(-3.72%)
733.39k

BLU Discussion

View Posts
mik1234 mik1234 4 years ago
it was a good day $$ BLU
👍️0
Oliverjack Oliverjack 4 years ago
insider bought 260k worth today monday 13th lol
👍️0
Bottom Feedr Bottom Feedr 4 years ago
Massive drop and ceo buys more! Hmmnnnn
👍️0
Bottom Feedr Bottom Feedr 4 years ago
Wake up sleepy head time to rock the market!
👍️0
dalesio_98 dalesio_98 6 years ago
Test
👍️0
RichardSawars RichardSawars 6 years ago
BLU to $3.
👍️0
TrendTrade2016 TrendTrade2016 6 years ago
BLU.TO hot canadian bio
👍️0
TrendTrade2016 TrendTrade2016 6 years ago
BLU is a beast!!
👍️0
TrendTrade2016 TrendTrade2016 6 years ago
The BLU beast!!
👍️0
TrendTrade2016 TrendTrade2016 6 years ago
put out a call on BLU.TO a monster bio play!!
👍️0
xr_biotech_consult xr_biotech_consult 8 years ago
happy to sold nearly 8000 during last days...only 4000 left for sale today.
👍️0
xr_biotech_consult xr_biotech_consult 8 years ago
2.99 weeeeEEEE°°
👍️0
xr_biotech_consult xr_biotech_consult 9 years ago
what shoud i say? 2.32 !!
👍️0
xr_biotech_consult xr_biotech_consult 9 years ago
2.08 !
👍️0
xr_biotech_consult xr_biotech_consult 9 years ago
yessss..new high..1.92
👍️0
xr_biotech_consult xr_biotech_consult 9 years ago
great Chart.. crushed 1,75 good sign. more will come
👍️0
xr_biotech_consult xr_biotech_consult 9 years ago
pivotal Phase 3 trail completed, top line results expected q2, fast track by FDA, rare desease, Long patent protection, Peak sales expected -1b ! ongoing Pipeline with rare deseases.. still great opportunity here
👍️0
xr_biotech_consult xr_biotech_consult 9 years ago
got ep 0.45 :
👍️0
xr_biotech_consult xr_biotech_consult 9 years ago
hrhr here weee goo
👍️0
xr_biotech_consult xr_biotech_consult 9 years ago
expected Prices per Patient per year 200-275 Thousand
👍️0
xr_biotech_consult xr_biotech_consult 9 years ago
Peak sales expected 600m - 1b
http://www.bellushealth.com/English/investors-and-news/presentations/default.aspx
👍️0
xr_biotech_consult xr_biotech_consult 9 years ago
News out
👍️0
xr_biotech_consult xr_biotech_consult 10 years ago
will move up again
👍️0
xr_biotech_consult xr_biotech_consult 10 years ago
target 2.50 CAD
👍️0
xr_biotech_consult xr_biotech_consult 10 years ago
yea hell great, new high hunts new high
👍️0
xr_biotech_consult xr_biotech_consult 10 years ago
BLU out in the blue
👍️0
xr_biotech_consult xr_biotech_consult 11 years ago
waht did i told u
👍️0
xr_biotech_consult xr_biotech_consult 11 years ago
massive breakout will come here
👍️0

Your Recent History

TSX
BLU
BELLUS Health
BIT
S25028
SG ISSUER
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved